GILD · News · 20260825N

Institutional Ownership Changes

GILEAD SCIENCES, INC. · 2026-08-25 · Importance 3 · Surprise 6

Legal & General Group Plc acquired more than 10.4 million Gilead shares during the second quarter for approximately $1.3 billion. The Manufacturers Life Insurance Company purchased more than 1 million shares valued at approximately $138 million. Dearborn Partners acquired 69,875 shares for approximately $9.74 million, while L2 Asset Management purchased 64,505 shares worth approximately $8.15 million. Gilead insiders, including CEO Daniel Patrick O'Day and CFO Andrew D. Dickinson, sold more than $11.5 million of shares during the prior 90 days.

Key facts

• Legal & General Group Plc acquired a new stake of over 10.4 million shares (10,421,131 shares) in Gilead Sciences, Inc. during the second quarter, valued at approximately $1.3 billion. source
• The Manufacturers Life Insurance Company purchased over 1 million shares of Gilead Sciences, Inc., valued at approximately $138 million. source
• Dearborn Partners LLC acquired a new position of 69,875 shares in Gilead Sciences, Inc. during the second quarter, valued at approximately $9.74 million. source
• Ieq Capital LLC acquired a new position of 33,739 shares in Gilead Sciences, Inc. during the second quarter, valued at approximately $4.26 million. source
• L2 Asset Management LLC purchased 64,505 shares of Gilead Sciences, Inc. during the second quarter, valued at approximately $8.15 million. source
• Manning & Napier Advisors LLC acquired a new stake worth $12.99 million in Gilead Sciences, Inc. during the second quarter. source
• Van Hulzen Asset Management LLC acquired 8,160 new shares of Gilead Sciences, Inc. valued at approximately $1.03 million during the second quarter. source
• Company insiders, including CEO Daniel Patrick O'day and CFO Andrew D. Dickinson, sold a significant number of Gilead Sciences, Inc. shares totaling over $11.5 million in the last ninety days. source